MIB1 and familial pancreatic carcinoma: Notably, combined silencing of ST7 and MIB1 diminished the antiproliferative effects of MIB1 downregulation in vitro and in vivo (Fig. 5H‐K), indicating that MIB1 promotes pancreatic cancer progression by targeting ST7 for degradation.